COVID-19 Impact on Integra Lifesciences Holdings Corp.’s Revenue and Operations (Medical Devices)

COVID-19 Impact on Integra Lifesciences Holdings Corp.’s Revenue and Operations (Medical Devices)

  • April 2020 •
  • 11 pages •
  • Report ID: 5930833 •
  • Format: PDF
COVID-19 Impact on Integra Lifesciences Holdings Corp.’s Revenue and Operations (Medical Devices)

Summary
Integra Lifesciences Holding Corp. (Integra),is a medical technology company which designs, develops, manufactures and markets a wide range of medical devices, headquartered in United States of America with global manufacturing and sales reach. Integra Lifesciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, CertasTM, Codman®, CUSA®, DuraGen®, DuraSeal® and many more. Company’s presence is seen in Wound care management, neurological devices, general surgery, orthopedic and dental devices. The report, COVID-19 Impact on Integra Lifesciences Holdings Corp.’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Integra Lifesciences Holdings Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Integra Lifesciences Holdings Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights
- The spread of the disease in recent days has put a much large proportion of Integra Lifesciences Holdings Corp’s at risk.
- In particular the heavy impact in Europe and rapid rise of COVID-19 cases in the US mean that the general outlook for sales has significantly declined in the past week.
- The company may experience a short term up tick in critical care devices, but will be impacted harshly due to presence in products related to elective procedures.

Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Integra Lifesciences Holdings Corp. -
- It provides insights on Integra Lifesciences Holdings Corp.’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy
- An overview of how Integra Lifesciences Holdings Corp. will be affected by the COVID-19 pandemic.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.